Recorded Chinese product: 甲酰四氢叶酸钙注射液甲酰四氢叶酸钙注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司
主要成分Active Ingredients
- 口服葡萄糖Koufu Putao Tang
药物知识说明
口服葡萄糖是一种在国家药监局注册认定的药品。该药品含有口服葡萄糖-e9d28095等成分。
该药品关联的活性成分包括：口服葡萄糖Koufu Putao Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司。
您可以探索含有相同成分的其他药品：口服葡萄糖-e9d28095成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 甲酰四氢叶酸钙注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 口服葡萄糖Koufu Putao Tang.
Manufacturers recorded for this product: 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司.
Explore other medicines containing the same ingredient: products containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 甲酰四氢叶酸钙注射液Recorded Chinese product: 甲酰四氢叶酸钙注射液
- 商品名Trade name: 口服葡萄糖
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 15毫克片剂Recorded Chinese specification: 15毫克片剂
- 命名冲突：来源不一致，以下仅展示已记录字段，未裁定唯一英文名。Name conflict across sources; showing recorded fields only; no invented English name.
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 赤峰蒙欣药业有限公司Chinese legal name: 赤峰蒙欣药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H15021455
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (BLOCKED)Package-insert database (more than 100,000 records) (BLOCKED)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H15021455
Manufacturer
Chinese legal name: 赤峰蒙欣药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H15021455
生产企业
赤峰蒙欣药业有限公司(国产)
适应症
本品为营养药，补充热能和体液。用于各种原因引起的进食不足或大量体液丢失(如呕吐、腹泻等)。
用法用量
1）因叶酸缺乏引起的巨幼细胞性贫血：推荐最初剂量为每日肌注9-12mg或口服7.5mg，连续使用10-15天。如疗效满意，可将剂量降低至能保证足够临床治疗效果的水平，直至血象正常，症状消失为止。2）当用于治疗叶酸拮抗剂之毒性及不良反应时观察到任何毒副反应，应尽早进行治疗，并据骨髓抑制情况，调校其剂量。常用剂量为每日肌注一至二次，每次3至6mg。直至血象恢复正常为止。3）作大剂量甲氨喋呤解毒剂，不同病人亚叶酸钙剂量差异很大。需紧密监测甲氨喋呤从血浆排除率来决定最佳剂量。继续服用亚叶酸钙直至甲氨喋呤浓度低于2×10-8mol/l。以下为用于解救大剂量甲氨喋呤时不同的亚叶酸钙剂量指导：一般情况，在甲氨喋呤静滴后24小时开始亚叶酸钙治疗，以15毫克静注，口服或肌注11次，每隔6小时1次。
不良反应
尚不明确。
禁忌
尚不明确。
注意事项
当药品性状发生改变时禁止使用。儿童必须在成人监护下使用。
贮藏
密封
规格
聚乙烯袋包装，350g/袋。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.